There is an individual variation in biological reactions in humans to medicinal products. This is why some of adverse reactions associated with the use of medicinal products cannot be detected during clinical trials.
Detecting as many of these adverse reactions, (including rare adverse reactions), is of paramount importance for continued patient and drug safety (pharmacovigilance).
As Orchidia products are available outside our national borders in 32 countries, mainly in MEA region, pharmacovigilance complies with worldwide regulations.
To enable orchidia to provide up-to-date safety information on orchidia products, your support is pivotal,
whether you are a customer, patient or healthcare professional